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Abstract
The inflammasome regulates release of caspase activation-dependent cytokines, including IL-1β,
IL-18, and high-mobility group box 1 (HMGB1)1-5. During the course of studying HMGB1
release mechanisms, we discovered an important role of double-stranded RNA dependent protein
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tkinase (PKR) in inflammasome activation. Exposure of macrophages to inflammasome agonists
induced PKR autophosphorylation. PKR inactivation by genetic deletion or pharmacological
inhibition severely impaired inflammasome activation in response to double-stranded RNA, ATP,
monosodium urate, adjuvant aluminum, rotenone, live E. coli, anthrax lethal toxin, DNA
transfection, and S. Typhimurium infection. PKR deficiency significantly inhibited the secretion of
IL-1beta, IL-18 and HMGB1 in E. coli-induced peritonitis. PKR physically interacts with multiple
inflammasome components, including NLR family pyrin domain-containing 3 (NLRP3), NLR
family pyrin domain-containing 1 (NLRP1), NLR family CARD domain-containing protein 4
(NLRC4), Absent in melanoma 2 (AIM2), and broadly regulates inflammasome activation. PKR
autophosphorylation in a cell free system with recombinant NLRP3, ASC and pro-casapse-1
reconstitutes inflammasome activity. These results reveal a critical role of PKR in inflammasome
activation, and indicate that it should be possible to pharmacologically target this molecule to treat
inflammation.
High-mobility group box 1 (HMGB1), a ubiquitous nuclear and cytosolic protein, is released
into the extracellular space during sterile inflammation and infection 6. Immunocompetent
cells secrete HMGB1 following stimulation with microbial products and other danger
signals 4-6. Ischemic and injured somatic cells also release HMGB1, but in this case the
release mechanisms are passive 6. Extracellular HMGB1 signals through TLR4 receptors in
macrophages to induce cytokine release 6-7, and mediate cell migration by interacting with
RAGE 8. The importance of these mechanisms in disease pathogenesis has been established,
because neutralizing HMGB1 attenuates disease severity in arthritis, colitis, sepsis, ischemia
reperfusion, and other infectious and sterile injury syndromes 6. The mediator role of
HMGB1 at the intersection of both sterile and infectious inflammation highlights the
importance of mechanisms that regulate the secretion of HMGB1 from immune cells 6.
Early observations suggested that secretion of HMGB1 from macrophages requires
inflammasome and caspase activity 3-5, 9-10, and is highly associated with HMGB1
translocation from nucleus to cytoplasm 4, 6. HMGB1 is also a universal sentinel to viral
invasion, and its release can be stimulated by Poly I:C, a double-stranded RNA (dsRNA)
mimetic 11-12. Interested in studying HMGB1 release mechanisms from macrophages
exposed to Poly I:C, we first considered earlier observations that double-stranded RNA
dependent kinase (PKR) is phosphorylated in these conditions 13-14. As PKR is also
activated by prototypical PAMPs and DAMPs known to stimulate HMGB1 release 15-16,
and activate the inflammasome, we reasoned that PKR activation might participate in
inflammasome activation.
Accordingly, we measured HMGB1 release by peritoneal macrophages obtained from PKR-
deficient (PKR-/-) mice, in which the PKR kinase domain had been functionally inactivated
by genetic deletion 16. HMGB1 secretion following Poly I:C exposure in PKR-/-
macrophages was significantly decreased as compared to wild-type (PKR+/+) macrophages
(Fig. 1a). Pharmacological inhibition of PKR in PKR+/+ macrophages dose-dependently,
and significantly, inhibited Poly I:C-induced HMGB1 release and PKR phosphorylation
(Fig. 1b, Supplementary Fig. 1). Other prototypical danger signals, including ATP,
monosodium urate (MSU), adjuvant aluminum (ALU), and live E. coli also significantly
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tincreased PKR phosphorylation and HMGB1 release (Fig. 1c-e). Addition of potassium to
the extracellular space significantly inhibited ATP induced PKR activation (Fig. 1c).
Inactivation of macrophage PKR by genetic deletion (Fig. 1d-e) or pharmacological
inhibition (Fig. 1f, Supplementary Fig. 2) also significantly inhibited HMGB1 release.
Pyroptosis, a form of programmed, inflammatory cell death, occurs with macrophage
inflammasome activation, and we observed that deletion of PKR significantly inhibited
LDH release (Fig. 1g). Analysis by tandem mass spectrometry of HMGB1 released in
response to ATP, MSU, or ALU indicated that HMGB1 was highly acetylated in the nuclear
location sequence (NLS) (Fig. 1h, Supplementary Fig. 3-6). In contrast, HMGB1 released
from macrophages subjected to freeze/thaw cycles was not acetylated in the NLS (Fig. 1h).
Together with evidence that inflammasome activation participates in the nuclear
translocation of HMGB1 4, these results indicated that HMGB1 hyperacetylation and
release, and inflammasome activation, are regulated by PKR.
To address the role of PKR in activating the NLRP3 inflammasome, we measured caspase-1
activation and IL-1β cleavage in peritoneal macrophages from PKR+/+ and PKR-/- mice.
Caspase-1 activation and IL-1β cleavage were significantly inhibited in PKR-/- macrophages
stimulated by exposure to ATP, MSU and ALU (Fig. 2a). Similar results were obtained in
bone-marrow-derived dendritic cells (Supplementary Fig. 7) and macrophages
(Supplementary Fig. 8). The expression of NLRP3 and pro-IL-1β did not differ significantly
in PKR-/- macrophages as compared to PKR+/+ macrophages (Fig. 2a, Supplementary Fig.
9), but IL-1β secretion by macrophages exposed to live E coli. was significantly inhibited in
PKR-/- macrophages as compared to PKR+/+ macrophages (Fig. 2b). TNF release in the
PKR+/+ and PKR-/- macrophages was comparable, indicating that the decreased release of
IL-1β in the PKR-/- macrophages is not attributable to a global defect in signal transduction
(Supplementary Fig. 10).
Transfection with Poly I:C and E. coli RNA in bone-marrow derived dendritic cells
significantly activated caspase-1 and stimulated IL-1β cleavage in PKR+/+, but not PKR-/-
cells (Supplementary Fig. 11). Similar observations were obtained in PKR-/- and
PKR+/+macrophages stimulated by rotenone, which induces mitochondrial ROS production
and PKR phosphorylation (Supplementary Fig. 12, 13). Pharmacological inhibition of PKR
dose-dependently suppressed MSU-induced caspase-1 activation and IL-1β cleavage. The
observed IC50’s of 2-AP and C13H8N4OS were 0.5 mM and 0.25 μM respectively, which
agree closely with their known IC50 against PKR (Fig. 2c, Supplementary Fig. 14). PKR
inhibition significantly reduced ATP- and ALU-induced inflammasome activation in murine
macrophages (Supplementary Fig. 15, 16), and in human monocytic THP-1 cells
(Supplementary Fig. 17). IL-18 release was significantly decreased in PKR-/- macrophages
as compared with PKR+/+ macrophages stimulated with ATP, MSU or ALU, whereas TNF
and IL-6 were not suppressed (Supplementary Fig. 18). Addition of 2-AP reduced MSU-
induced IL-18 release, but not TNF and IL-6 (Supplementary Fig. 18). 2-AP failed to inhibit
MSU-induced caspase-1 activation and IL-1 β cleavage in PKR-/- macrophages
(Supplementary Fig.19). Collectively, these findings establish a critical role for PKR in
activating the NLRP3 inflammasome.
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tPKR+/+ and PKR-/- mice were then exposed to live E. coli, in order to activate the NLRP3
inflammasome in vivo 17. Serum IL-1β, IL-18, and HMGB1 were significantly reduced in
PKR-/- mice as compared to PKR+/+ mice (Fig. 2d). In agreement with prior evidence
suggesting that peritoneal neutrophil infiltration requires inflammasome activation 18, we
observed significantly fewer neutrophils in peritoneal lavage from PKR-/- mice as compared
to PKR+/+ controls (Fig. 2e). Serum IL-6, an inflammasome independent cytokine, was
comparable in both groups (Fig. 2d). Exposure of PKR-/- mice to endotoxemia produced
significantly lower serum IL-1β and IL-18 levels, but quantitatively similar serum levels of
TNF and IL-6 as compared to PKR+/+ controls (Supplementary Fig. 20). Thus, PKR
regulates inflammasome-dependent cytokine release in vivo.
To study the mechanisms, HEK293A cells, which do not normally express the NLRP3
components, were transfected with plasmids that co-express ASC, pro-caspase-1, and
NLRP3. These modified cells were then co-transfected with plasmids that express PKR, or
specific short hairpin RNA (shRNA) to suppress endogenous PKR. Overexpression of PKR
significantly enhanced caspase-1 activation and IL-1β cleavage, and knockdown of
endogenous PKR by shRNA abolished caspase-1 cleavage in the NLRP3 inflammasome-
reconstituted cells (Fig. 2f, g). IL-1β cleavage was significantly abrogated by
pharmacological inhibition of PKR (Supplementary Fig. 21). PKR overexpression failed to
directly activate caspase-1 in the absence of NLRP3 (Supplementary Fig. 22), and did not
enhance HMGB1 release in the absence of caspase-1 (Supplementary Fig. 23). Knock-down
of endogenous eIF-2a, a PKR substrate 13-14, did not alter HMGB1 release and IL-1β
cleavage in the NLRP3 inflammasome-reconstituted cells (Supplementary Fig. 24).
We therefore reasoned that PKR physically interacts with the NLRP3 inflammasome, and
prepared mouse macrophage lysates for immunoprecipitation using anti-PKR antibodies.
PKR pulled down NLRP3, and reciprocal immunoprecipitation of NLRP3 pulled down PKR
(Supplementary Fig. 25). Similar observations were obtained in human THP-1 cells
(Supplementary Fig. 26). PKR-NLRP3 complexes could not be detected in the PKR-/-
macrophages (Supplementary Fig. 27). Co-expression of PKR and NLRP3 in HEK293A
cells, followed by immunoprecipitation, confirmed the physical interaction between PKR
and NLRP3. PKR failed to physically associate with the other cytosolic receptors and
inflammasome family members NOD1, NLRP12, or NLRX1 (Supplementary Fig. 28). PKR
co-immunoprecipitated with truncated forms of NLRP3 containing the PYD, NACHT, and
LRR domains (Supplementary Fig. 29), and with the Walker A mutant form of NLRP3
(Supplementary Fig. 30), which can not bind ATP 19. Together with direct evidence that
recombinant PKR forms a heteromeric protein complex with NLRP3 (Fig. 3a), these results
indicate that PKR physically interacts with the inflammasome.
Exposure of PKR+/+ macrophages to ATP significantly enhanced formation of NLRP3 and
PKR complexes (Fig. 3b). Pharmacological inhibition of PKR phosphorylation by 2-AP and
C13H8N4OS significantly suppressed the formation of NLRP3-PKR complexes (Fig. 3b).
Addition of Poly I:C and ATP to NLRP3 and PKR in a cell-free system significantly
induced PKR phosphorylation and increased the formation of NLRP3-PKR complexes (Fig.
3a).
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tNext, the NLRP3 inflammasome was reconstituted in a cell free system with recombinant
NLRP3, ASC, pro-caspase-1 and PKR. Combining NLRP3 and ASC with Pro-caspase-1
failed to increase caspase-1 activity (Fig. 3c). Addition of PKR and Poly I:C/ATP
significantly increased caspase-1 activity, which was inhibited by the addition of 2-AP (Fig.
3c). PKR activity is required in this cell free system, because poly I:C/ATP failed to increase
NLRP3 inflammasome activity in the absence of PKR. Moreover, replacing PKR with a
recombinant, mutant PKR (K296R) devoid of kinase activity 13, 16, failed to activate the
NLRP3 inflammasome (Fig. 3c). Although PKR is an autophosphorylating kinase, it was
theoretically possible that PKR might phosphorylate inflammasome components directly.
Phosphorylation of NLRP3, ASC, and Caspase-1 could not be detected, although Poly
I:C/ATP significantly stimulated autophosphorylation of PKR (data not shown). To confirm
that PKR autophosphorylation is involved in NLRP3 inflammasome activation, PKR K296R
mutant and NLRP3 inflammasome components were co-expressed in HEK293A cells. PKR
K296R mutant failed to bind NLRP3, whereas WT PKR did bind NLRP3 (Supplementary
Fig. 31). Overexpression of PKR K296R mutant failed to activate the reconstituted NLRP3
inflammasome in HEK293A cells (Supplementary Fig. 31). Together, these data indicate
that PKR physically interacts with NLRP3 and is critical for inflammasome activation.
Reasoning that PKR might associate with the inflammasome components during assembly,
ATP stimulated macrophage lysates were subjected to gel filtration chromatography. We
observed that PKR and NLRP3 eluted together with ASC and caspase-1 in the high
molecular weight fraction of the ATP-stimulated macrophage extract (Fig. 3d,
Supplementary Fig. 32). Inhibition of PKR activation by 2-AP reduced PKR in the high
molecular weight inflammasome fraction (Fig. 3d, Supplementary Fig. 33). Expression of
the PKR K296R mutant significantly reduced NLRP3 in the high-molecular weight
inflammasome fraction, without significantly changing total NLRP3 expression
(Supplementary Fig. 34). Rendering cells deficient in PKR also significantly impaired the
formation of high-molecular weight protein NLRP3 inflammasome complexes, without
altering total NLRP3 protein expression levels (Supplementary Fig. 35). Activation of
macrophages by exposure to ATP, MSU, ALU, or E. coli significantly shifted caspase-1
from the low molecular weight, monomeric fraction, to the high-molecular weight protein
complexes in PKR+/+ macrophages, but not in PKR-/- macrophages (Supplementary Fig.
35). Thus, activated PKR is an integral component of the assembled inflammasome.
Unexpectedly, PKR also physically interacted with NLRP1, AIM2, and NLRC4 when co-
expressed in HEK293A cells (Fig. 4a). To address whether PKR might also regulate
NLRP1, AIM2, and NLRC4 inflammasomes, macrophages were stimulated with anthrax
lethal toxin (LT), Poly (dA:dT) transfection, or S. Typhimurium to activate NLRP1, AIM2,
and NLRC4 inflammasome, respectively. This significantly enhanced PKR
autophosphorylation (Supplementary Fig. 36). Inactivation of PKR by genetic deletion (Fig.
4b-d, Supplementary Fig. 37, 38) or pharmacological inhibition (Fig. 4e, Supplementary Fig
39) significantly inhibited caspase-1 activation, IL-1β cleavage, and HMGB1 secretion.
LDH release and IL-18 production were also significantly decreased in PKR-/- macrophages
as compared with PKR+/+ macrophages, whereas TNF production was not suppressed in
these conditions (Supplementary Fig. 40, 41). Overexpression of PKR significantly
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tenhanced NLRP1, AIM2, and NLRC4 inflammasome-induced caspase-1 activation and
IL-1β cleavage in HEK293A cells (Fig. 4f, Supplementary Fig. 42). Thus, PKR regulates the
activation of the NLRP3, NLRP1, AIM2, and NLRC4 inflammasomes, but PKR activity
does not determine which inflammasome will be activated in response to a specific stimulus.
Previous observations suggested that macrophage death via pyroptosis might initiate
deleterious inflammatory responses and compromise immunity during bacterial
infection 5, 15, and that PKR can participate in bacteria-induced macrophage death 15. To
assess whether PKR deficiency impairs bacterial clearance, PKR+/+ and PKR-/- mice were
exposed to live E. coli (bearing a genetic marker) into the peritoneal cavity. Titers of the
genetically labeled bacteria in the spleen and peritoneal cavity 24 hours later were
significantly lower in PKR-/- mice as compared to PKR+/+ controls (Supplementary Fig. 43),
indicating that animals maintain the capacity to clear bacteria despite PKR deficiency.
This study establishes that PKR activity is integral to inflammasome assembly and
activation. PKR physically interacts with inflammasome components, is important for
caspase-1 activation, IL-1β cleavage, and HMGB1 release, and mediates inflammasome
activity in a cell-free system. Although originally studied as an intracellular sensor of viral
dsRNA, a broader role of PKR was recently suggested as a danger sensing molecule
activated by cellular and metabolic stress 15-16, 20. Together with the established role of the
inflammasome and HMGB1 in sterile and infection-associated inflammation 3, 6, 21-23, the
identification here of PKR as a critical regulator of inflammasome activity adds importantly
to understanding mechanisms of innate immune responses to environmental, metabolic, and
invasive signals.
Rapidly growing evidence links the inflammasome to the pathogenesis of obesity, type 2
diabetes, atherosclerosis, gout, sepsis, colitis, and other disease syndromes 4-5, 10, 18, 24-25.
The development of therapeutics targeting the inflammasome requires knowledge of specific
upstream signaling pathways that regulate inflammasome assembly and activation 25-26. It
should now be possible to design and develop therapeutics to inhibit inflammasome activity
by specifically targeting PKR, without broadly impairing immunity, in the treatment of non-
resolving inflammatory and metainflammatory syndromes.
METHODS
Mice
The PKR-/- mice and their littermates wild-type controls originally are in the mixed 129Sv /
BALB/C background as described previously 16. In E.coli infection and endotoxemia
experiments, we used the mice that had been bred into the C57Bl/6J genetic background.
Genome-wide SNP analysis confirmed that about 98% of the genetic background of these
mice is of C57Bl/6J. Animal care and experimental procedures were performed with
approval from the Institutional Animal Care and Use Committees (IACUC) of The Feinstein
Institute for Medical Research and Harvard University. PKR-/- and PKR+/+ mice are
genotyped with PCR primers (5’-GGAACTTTGGAGCAATGGA-3 ’ ; 5 ’-
TGCCAATCACAAATCTAAAAC-3′; 5’-TGTTCTGTGGCTATCAGGG-3′ and 5 ’-
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tTGACGAGTT CTTCTGAGGG-3′) yielding a 240 bp wild-type DNA band and 460 bp
mutant DNA band after electrophoresis in 2% agarose gel in TAE.
Reagents
Ultra-pure LPS and the NLRP3 inflammasome agonists ATP, monosodium urate crystal
(MSU), and adjuvant aluminum (ALU) were obtained from Invivogen. The anti-NLRP3
antibodies (Cryo-2) were from Adipogen. The rabbit monoclonal anti-PKR (phospho T446)
antibodies (E120) were from Abcam. Mouse HMGB1 mAb IgG2b 2G7 was described
previously 7, 10. eIF2a siRNA molecules and their negative controls were obtained from Life
Technologies (Catalog: 4392420). Recombinant NLRP3 protein was obtained from Abnova.
Recombinant Flag-tagged PKR protein was purified from PKR-/- mouse embryonic
fibroblast cells stably expressing Flag-tagged PKR. Recombinant Flag-tagged ASC and
Procaspase-1 protein were purified from HEK293A cells overexpressing Flag-tagged ASC
and Procaspase-1(Origene). Anti-human cleaved IL-1 β (D116) was purchased from Cell
Signaling. Anti-mouse IL-1β (sc-1251), anti-mouse caspase-1 (sc-514), and anti-human
caspase-1 (sc-622) antibodies were from Santa Cruz.
Cell preparation and stimulation
Peritoneal macrophages were isolated and cultured as described previously 7. Primary bone
marrow derived macrophages (BMDMs) and bone marrow derived dendritic cells (BMDCs)
were cultured and differentiated in vitro as described previously 18. Human THP1 cells were
differentiated for 3 h with 100nM phorbol-12-myristate-13-acetate (PMA). 106 peritoneal
macrophages, BMDMs, BMDCs, or PMA-differentiated THP1 cells plated in 12-well plates
were primed with ultra-pure LPS (500 ng/ml) for 4 h, and then stimulated with MSU (150
μg/mL), ALU (200 μg/mL) for 5 h, or live E. coli (MOI=20) for 6 h (stop the bacteria
growth by adding antibiotics into culture medium 1 h after infection), or pulsed with ATP (5
mM) for 30 min or 1 hour as indicated. Ultra-pure LPS (1 ng/ml) primed mouse peritoneal
macrophages were stimulated with Poly I:C (50 μg/ml) for 16 h. For salmonella infection,
wild-type S. typhimurium was grown overnight in Luria-Bertani broth, then was reinoculated
at a dilution of 1:100 and grown to mid-exponential phase (3 h) to induce expression of the
salmonella pathogenicity island 1 type III secretion system. To minimize the involvement of
NLRP3 inflammasome activation during salmonella infection, unprimed PKR+/+ and PKR-/-
macrophages were infected with wild-type S. typhimurium (multiplicity of infection is from
5 to 100). The supernatant samples were collected 1 h after infection. To study AIM2
inflammasome activation, PKR+/+ and PKR-/- macrophages were transfected with
Poly(dA:dT) using Lipofectamine 2000 at a concentration of (1μg DNA plus 3.5μl
Lipofectamine 2000 per ml. The supernatant samples were collected 6 h after transfection.
Caspase-1 activation, HMGB1 and LDH release were analyzed. To study the DNA-
transfection-induced IL-1β cleavage, LPS-primed PKR+/+ and PKR-/- macrophages were
transfected with Poly (dA:dT)/Lyovec (Invivogen) at a concentration of 5μ/ml. There is
minimum cell death with this approach. Cell lysates and precipitated supernatants were
analysed by Western blot analysis.
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tPharmacological inhibition of PKR
PKR inhibitor 2-Aminopurine (2-AP) was purchased from Sigma. 2-AP was dissolved in
phosphate-buffered saline: glacial acetic acid (200:1) at 60°C for 60 min. PKR inhibitor
C13H8N4OS was purchased from Calbiochem. Ultra-pure LPS-primed peritoneal mouse
macrophages, BMDMs, BMDCs, or PMA-differentiated THP1 cells were pre-treated with
2-Aminopurine (2-AP) (0.5 or 1.0 mM) or C13H8N4OS (0.25 or 0.5 μM) for 1 to 4 h before
stimulating with various inflammasome activators. Higher concentrations of above PKR
inhibitors are not recommended due to off-target effects. Cell lysates and precipitated
supernatants were analysed by Western blot.
ELISA
Cell culture supernatants and mouse serum samples were assayed for mouse IL-1β, IL-6,
TNF, IL-18 (R&D Systems), and HMGB1 (IBL INTERNATIONAL) according to the
manufacturer’s instructions.
Transfection
106 BMDCs from PKR+/+ or PKR-/- mice were primed with ultra-pure LPS for 2 h, and then
transfected with 5 μg of Poly I:C by lipofectamine 2000 for 6 h. In another set of
experiment, ultra-pure LPS primed BMDCs (106 cells) from PKR+/+ or PKR-/- mice were
transfected with 5 μg of Poly I:C or E. coli RNA (Ambion) by electroporation using
Nucleofector (Program V-01) and cell line Nucleofector Kit V (Amaxa AG). 3 h later, cell
extracts and precipitated supernatants were obtained and analysed by Western blot analysis.
Reconstituted inflammasome in HEK293A cells
For the human NLRP3 inflammasome reconstitution assays, 0.2 × 106 HEK293A cells were
seeded onto 24-well plates in cell culture media lacking antibiotics. 24 h later, cells were
transfected with plasmids expressing pro-IL-1β and inflammasome components (Origene),
such as ASC, pro-caspase-1, NLRP3, or NLRP1, using lipofectamine 2000. These modified
cells were then co-transfected with plasmids that express PKR (Catalog: puno-hPKR,
Invivogen), or specific shRNA (Catalog: ksina42-hpkr, Invivogen) to knockdown the
endogenous PKR. The total amount of DNA was standardized to 600 ng per well using a
control plasmid. 24 h later, cell lysates were harvested and analyzed for IL-1β maturation
and Caspase-1 cleavage by Western blot analysis.
Immunoprecipitation
Antibodies against the PKR, NLRP3, Flag, or Myc were used to precipitate proteins from
cell lysis in the presence of 20μl protein A/G beads (Santa Cruz) overnight at 4°C. Protein
complexes were washed four times with lysis buffer, and then incubated at 95°C for 5
minutes and resolved by Western blot analysis.
Western-blot
Proteins from cell-free supernatants were extracted by methanol/chloroform precipitation as
described previously 18. Cell extracts were prepared as described previously 7. Samples were
separated by 4-20% SDS-PAGE or 4-20% native-PAGE and were transferred onto PVDF
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tmembranes. The relative levels of HMGB1 in the culture medium were determined by
Western blot analysis using recombinant HMGB1 protein to make a standard curve.
PKR autophosphorylation assay
PKR phosphorylation were assessed by PKR autophosphorylation assay as described
previously 15, 16. For mouse cells-derived samples, PKR autophosphorylation assay is
recommended.
Gel Filtration Chromatography
As described early 19, fresh soluble lysates from mouse macrophages were prepared by
hypotonic lysis and shearing through a 27-gauge needle. Soluble lysate (0.6 mg of total
protein) was run on a Biosil 400 gel filtration column using a Bio-Rad Duoflow
chromatography system in PBS with 2 mM DTT.
Reconstituted inflammasome in a cell-free system
Recombinant NLRP3, ASC and pro-caspase-1 were incubated with recombinant PKR and
ATP (2.5mM) /Poly I:C (0.001 μg/mL) in the PKR reaction buffer (20 mM HEPES [pH7.4],
10 mM MgCl2, 40 mM KCl, 2 mM DTT) at 37 °C for 1 h. Caspase-1 activity was measured
by hydrolysis of WEHD-pNA.
E. coli-induced peritonitis and endotoxemia model
PKR-/- and PKR+/+ mice were injected i.p. with live E. coli (2×109 per mouse). 6 h later,
blood was collected and serum levels of IL-1β, IL-18, HMGB1, and IL-6 were measured by
ELISA. Meanwhile, peritoneal cavities were washed with 10 ml of PBS. The lavage fluids
were analysed for neutrophil influx by Flow cytometry using the neutrophil marker GR-1.
For bacterial titers experiments, PKR+/+ and PKR-/- mice received live 2×109 E.coli into
peritoneal cavity. And bacterial titers in both peritoneal cavity and spleen were measured 24
hour after E.coli challenge. To prevent other bacterial contamination during sample
collection process, the E.coli had been transformed with an ampicillin-resistant gene. And
bacterial titers were determined using ampicillin-containing LB agar plates. For
endotoxemia experiments, PKR-/- and PKR+/+ mice received 20mg/kg of LPS and blood
was collected 2.5 hour later. Serum IL-1β, IL-18, TNF, and IL-6 levels were determined by
ELISA.
Analysis of HMGB1 by tamdem mass spectrometry
Detailed methods are available in Supplemetary Figures and Methods.
Statistical analysis
Student’s t-test and one-way ANOVA were used for comparison among all different groups.
A p value < 0.05 was considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFig. 1. Role of PKR in pyroptosis-mediated HMGB1 release
a-b. Cells were stimulated with Poly I:C. (a) Macrophages from PKR+/+ or PKR-/- mice. (b)
PKR+/+ macrophages treated with indicated doses of the PKR inhibitor 2-AP. c. LPS-primed
PKR+/+ macrophages were stimulated or treated with or without potassium-substituted
medium (KCl) as indicated. Cells were lysed at indicated time points and PKR activation
was monitored by autophosphorylation. d-g. LPS-primed PKR+/+ or PKR-/- macrophages
were stimulated or treated with 2-AP as indicated. HMGB1 levels in the supernatant were
determined by Western blot. Cytotoxicity was determined by LDH assay. Data shown are
means ± SD of 3 independent experiments. #, p<0.05 vs. wild-type stimulated groups. h.
Mass-spectrometric analysis of acetylation status of nuclear location sequences (NLS) of
HMGB1.
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tFig. 2. PKR is important for inflammasome activation
a-b. LPS-primed PKR+/+ or PKR-/- macrophages were stimulated as indicated. c. PKR+/+
macrophages were stimulated or treated with 2-AP or C13H8N4OS (CNS) as indicated. d-e.
PKR+/+ or PKR-/- mice (n=5) were injected with live E. coli. f-g. HEK293A cells were
transfected as indicated. Caspase-1 activation and IL-1β cleavage were assessed by Western-
blot. Data are representative of at least three independent experiments. Levels of IL-1β,
IL-18, HMGB1, and IL-6, in the supernatant (b) or serum (d) were determined by ELISA.
Peritoneal lavage fluid was collected and neutrophil content measured by flow cytometry
(e). Data shown are means ± SD. #, p<0.05 vs. wild-type infected groups.
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tFig. 3. PKR physically interacts with NLRP3 and facilitates inflammasome activation
a-b. Immunoprecipitation (IP) and Western-blot (WB) analysis of the physical interaction of
PKR and NLRP3 in cell-free system using recombinant proteins (a) or LPS-primed
macrophages stimulated with ATP or treated with of 2-AP or C13H8N4OS (CNS) as
indicated (b). c. The NLRP3 inflammasome was reconstituted using recombinant proteins
and ATP/Poly I:C as indicated. Caspase-1 activity was measured by hydrolysis of WEHD-
pNA. d. PKR+/+ macrophages were stimulated or treated with 2-AP as indicated. Cell
lysates were subjected to gel-filtration chromatograph and western-blot. Results are
representative of three independent experiments.
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tFig. 4. PKR regulates NLRP1, AIM2, NLRC4 inflammasome activation
a. HEK293A cells were transfected as indicated. The physical interaction of PKR and myc-
tagged proteins was analyzed by Immunoprecipitation (IP) and Western-blot (WB) analysis.
b-d. LPS-primed (b) or unprimed (c, d) PKR+/+ or PKR-/- macrophages were stimulated with
Anthrax lethal toxin (LT), or transfected with Poly (dA:dT), or infected with S.
Typhimurium (S.T). MOI, multiplicity of infection. e. PKR+/+ macrophages were stimulated
or treated with 2-AP as indicated. f. HEK293A cells were transfected as indicated.
Caspase-1 activation, IL-1β cleavage, and HMGB1 secretion were assessed by Western-blot.
Results are representative of at least three independent experiments.
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